One of China’s leading generic pharmaceutical companies has purchased the rights to commercialise an experimental drug developed by the Chinese military for treating Ebola, though medical experts said the drug is still at an early stage of development.
中國一家領先的仿製藥公司買下了中國軍方研發的一種實驗性埃博拉藥物的商業化權利，儘管醫學專家們表示，這種藥物仍處於早期開發階段。
您已閱讀6%（315字），剩餘94%（5246字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。